Cadient Group

Share this article:
Cadient Group
Cadient Group
Cadient Group

Five Tower Bridge, 300 Barr Harbor Drive, Suite 400,
West Conshohocken, PA 19428
Phone: 484-351-2800 · Fax:484-351-2900
Email: info@cadient.com · Web: www.cadient.com
Founded: 2003 Officers: Stephen Wray, chairman of the board/president; Greg Lewis, VP, customer engagements; VP’s, marketing strategy: Bob Holloway, Will Reese; Heather Torak,VP, agency operations.



U.S. billings breakdown by media/source:

Medium 2005 2004
Alternative Media 72.0% 76.0%
Conventions/ exhibits 28.0% 24.0%

Healthcare accounts: AstraZeneca, Pfizer, Inc., Novartis, Johnson & Johnson, Shire plc, Amgen, ZLB Behring.

Accounts gained (25): 7 Consumer Rx, 3 Consumer OTC, 15 Professional Rx.

Accounts lost (0):

Services: Opportunity assessments: insight and expertise on development of interactive marketing programs from prelaunch to generic defense. Consulting: long-term strategic, interactive guidance at the brand, franchise and/or corporate level. Creative: art direction, copywriting, graphic design, animation and video production; media: media planning, buying, organic, paid keyword SEM, consulting services in online advertising, and SEO. Research and Analytics: metrics, data and analysis to evaluate effectiveness and value of online efforts. Collaborative Solutions: proprietary acquisition and relationship marketing application for capturing and leveraging user information through the customer life cycle. Technical: solution architecture, Web site development, database design and development.
Share this article:
close

Next Article in Agency Gallery

Email Newsletters

More in Agency Gallery

Private View: Creating Compelling Experiences

Private View: Creating Compelling Experiences

In today's multi-channel environment, game-changing ideas blend creativity and sensory ideation to create a meaningful customer experience

Putting consumers at the center of your universe

Putting consumers at the center of your universe

The question should be: How do you simplify and identify the moments that mean the most to customers?

Did "pay-to-play" confab help Zohydro approval?

Did "pay-to-play" confab help Zohydro approval?

US senators Joe Manchin (D-WV) and David Vitter (R-LA) are asking whether a "pay-to-play" meeting between drug industry executives and FDA officials influenced the agency's approval of Zohydro